These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33828990)
21. Exploring the multifaceted role of key lncRNA in glioma: From genetic expression to clinical implications and immunotherapy potential. Zhao S; Liu M; Zhou H Heliyon; 2024 Sep; 10(17):e36822. PubMed ID: 39281521 [TBL] [Abstract][Full Text] [Related]
22. Identification of a Glycolysis-Related LncRNA Signature to Predict Survival in Diffuse Glioma Patients. Wang Y; Zhou W; Ma S; Guan X; Zhang D; Peng J; Wang X; Yuan L; Li P; Mao B; Kang P; Li D; Zhang C; Jia W Front Oncol; 2020; 10():597877. PubMed ID: 33614485 [TBL] [Abstract][Full Text] [Related]
23. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
24. A long non-coding RNA signature in glioblastoma multiforme predicts survival. Zhang XQ; Sun S; Lam KF; Kiang KM; Pu JK; Ho AS; Lui WM; Fung CF; Wong TS; Leung GK Neurobiol Dis; 2013 Oct; 58():123-31. PubMed ID: 23726844 [TBL] [Abstract][Full Text] [Related]
25. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma. Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL Front Oncol; 2020; 10():780. PubMed ID: 32587825 [No Abstract] [Full Text] [Related]
26. Unique metastasis-associated lncRNA signature optimizes prediction of tumor relapse in lung adenocarcinoma. Zhang X; Han J; Du L; Li X; Hao J; Wang L; Zheng G; Duan W; Xie Y; Zhao Y; Zhang X; Zou M; Wang C Thorac Cancer; 2020 Mar; 11(3):728-737. PubMed ID: 31994347 [TBL] [Abstract][Full Text] [Related]
27. Nine-long non-coding ribonucleic acid signature can improve the survival prediction of colorectal cancer. Zong Z; Hu CG; Zhou TC; Yu ZM; Tang FX; Tian HK; Li H; Wang H World J Gastrointest Surg; 2021 Feb; 13(2):210-221. PubMed ID: 33643540 [TBL] [Abstract][Full Text] [Related]
28. A Five Immune-Related lncRNA Signature as a Prognostic Target for Glioblastoma. Li X; Sun L; Wang X; Wang N; Xu K; Jiang X; Xu S Front Mol Biosci; 2021; 8():632837. PubMed ID: 33665208 [No Abstract] [Full Text] [Related]
29. A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma. Zhang H; Zhu M; Du Y; Zhang H; Zhang Q; Liu Q; Huang Z; Zhang L; Li H; Xu L; Zhou X; Zhu W; Shu Y; Liu P J Cancer; 2019; 10(6):1550-1559. PubMed ID: 31031865 [No Abstract] [Full Text] [Related]
30. The role of long non-coding RNA AFAP1-AS1 in human malignant tumors. Ji D; Zhong X; Jiang X; Leng K; Xu Y; Li Z; Huang L; Li J; Cui Y Pathol Res Pract; 2018 Oct; 214(10):1524-1531. PubMed ID: 30173945 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p. Yang JX; Liu B; Yang BY; Meng Q Neoplasma; 2018; 65(4):505-514. PubMed ID: 30064227 [TBL] [Abstract][Full Text] [Related]
32. Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy. Lv QL; Wang LC; Li DC; Lin QX; Shen XL; Liu HY; Li M; Ji YL; Qin CZ; Chen SH Front Pharmacol; 2020; 11():560543. PubMed ID: 33362537 [TBL] [Abstract][Full Text] [Related]
33. LncRNA SAMD12-AS1 down-regulates P53 to promote malignant progression of glioma. Yu BX; Zou L; Li S; Du YL Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8456-8467. PubMed ID: 31646576 [TBL] [Abstract][Full Text] [Related]
34. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma. Zhang J; Zhang X; Piao C; Bi J; Zhang Z; Li Z; Kong C Biomed Pharmacother; 2019 Oct; 118():109079. PubMed ID: 31351427 [TBL] [Abstract][Full Text] [Related]
35. Expression and prognostic value of mRNAs in lower grade glioma with MGMT promoter methylated. Wang W; Li J; Lin F; Guo J; Zhao J J Clin Neurosci; 2020 May; 75():45-51. PubMed ID: 32229069 [TBL] [Abstract][Full Text] [Related]
36. Cancer-associated methylated lncRNAs in patients with bladder cancer. Zhang S; Cao H; Ye L; Wen X; Wang S; Zheng W; Zhang Y; Huang D; Gao Y; Liu H; He H; Gao X; Chen Y; Chen M; Xiang Y; Wang F Am J Transl Res; 2019; 11(6):3790-3800. PubMed ID: 31312389 [TBL] [Abstract][Full Text] [Related]
37. A three-lncRNA signature derived from the Atlas of ncRNA in cancer (TANRIC) database predicts the survival of patients with head and neck squamous cell carcinoma. Cao W; Liu JN; Liu Z; Wang X; Han ZG; Ji T; Chen WT; Zou X Oral Oncol; 2017 Feb; 65():94-101. PubMed ID: 28109476 [TBL] [Abstract][Full Text] [Related]
38. Discovery of a novel six-long non-coding RNA signature predicting survival of colorectal cancer patients. Fan Q; Liu B J Cell Biochem; 2018 Apr; 119(4):3574-3585. PubMed ID: 29227531 [TBL] [Abstract][Full Text] [Related]
39. A nomogram combining long non-coding RNA expression profiles and clinical factors predicts survival in patients with bladder cancer. Wang Y; Du L; Yang X; Li J; Li P; Zhao Y; Duan W; Chen Y; Wang Y; Mao H; Wang C Aging (Albany NY); 2020 Feb; 12(3):2857-2879. PubMed ID: 32047140 [TBL] [Abstract][Full Text] [Related]
40. High Expression of lncRNA AFAP1-AS1 Promotes the Progression of Colon Cancer and Predicts Poor Prognosis. Bo H; Fan L; Li J; Liu Z; Zhang S; Shi L; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li G; Xiong W; Zeng Z; Xiong F; Gong Z J Cancer; 2018; 9(24):4677-4683. PubMed ID: 30588252 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]